HCS

Higher Ed Consolidation Solutions Facilitates Historic Merger Between the University of Findlay and Bluffton University

Retrieved on: 
Monday, March 25, 2024
HCS, Partnership, Trustee, Education, Student, University, Bluffton University, Faculty, Management

PEMBROKE PINES, Fla., March 25, 2024 /PRNewswire/ -- Higher Ed Consolidation Solutions (HCS), the nation's pioneering full-service consultancy specializing in college and university mergers, proudly announces the successful facilitation of a merger between the University of Findlay and Bluffton University.

Key Points: 
  • PEMBROKE PINES, Fla., March 25, 2024 /PRNewswire/ -- Higher Ed Consolidation Solutions (HCS), the nation's pioneering full-service consultancy specializing in college and university mergers, proudly announces the successful facilitation of a merger between the University of Findlay and Bluffton University.
  • "HCS has been an essential partner in our assessment of this exciting opportunity," remarked Katherine Fell, Ph.D., president of the University of Findlay.
  • We are grateful for their partnership as we announce today our decision to pursue a bold new vision for the University of Findlay together with Bluffton University."
  • Higher Ed Consolidation Solutions is proud to have facilitated this transformative merger, setting a new precedent for collaboration and innovation in higher education.

GTG to launch U.S. Customer Digital Media Sales Campaign

Retrieved on: 
Wednesday, February 28, 2024
Diabetes, HCP, Risk, Health, Meta, Atrial fibrillation, Health professional, Consumer, CIT, GTG, HCS, Coronary artery disease

MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted digital advertising campaign in the United States.

Key Points: 
  • MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted digital advertising campaign in the United States.
  • The campaign will commence end of March 2024 and will scale up throughout the remainder of the year.
  • The customer - targeted campaign will launch across multiple digital channels initially in the United States and will include a mix of earned organic content, paid media, and creator content.
  • GTG continues to market geneType to Healthcare Professionals (HCP) and Healthcare Systems (HCS) in Australia and the U.S.

Productlife Group Acquires Health Care Solution (HCS), Expanding Its Reach Across Middle East And Africa

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, PLG, Quality, Regulatory affairs, Consultant, HCS

PARIS, March 5, 2024 /PRNewswire-PRWeb/ -- Health Care Solution was founded in 2016 in Casablanca, Morocco, specializing in Regulatory Affairs, Quality and Industrialization consulting. It offers operational support, audit and training services across Middle East and Africa, leveraging its strong technical and regulatory know-how. These new regional capabilities will complement PLG's end-to-end regulatory solutions designed to streamline compliance strategies across global markets.

Key Points: 
  • With this alliance, PLG reinforces its ability to support client regulatory and compliance needs globally.
  • PARIS, March 5, 2024 /PRNewswire-PRWeb/ -- Health Care Solution was founded in 2016 in Casablanca, Morocco, specializing in Regulatory Affairs, Quality and Industrialization consulting.
  • It offers operational support, audit and training services across Middle East and Africa, leveraging its strong technical and regulatory know-how.
  • The HCS consultants will be involved on larger scale global projects, and PLG will support HCS in opening new doors in Middle East and Africa.

PRODUCTLIFE GROUP ACQUIRES HEALTH CARE SOLUTION (HCS), EXPANDING ITS REACH ACROSS MIDDLE EAST AND AFRICA

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, PLG, Quality, Regulatory affairs, Consultant, HCS

With this alliance, PLG reinforces its ability to support client regulatory and compliance needs globally.

Key Points: 
  • With this alliance, PLG reinforces its ability to support client regulatory and compliance needs globally.
  • Health Care Solution was founded in 2016 in Casablanca, Morocco, specializing in Regulatory Affairs, Quality and Industrialization consulting.
  • It offers operational support, audit and training services across Middle East and Africa, leveraging its strong technical and regulatory know-how.
  • The HCS consultants will be involved on larger scale global projects, and PLG will support HCS in opening new doors in Middle East and Africa.

PRODUCTLIFE GROUP ACQUIRES HEALTH CARE SOLUTION (HCS), EXPANDING ITS REACH ACROSS MIDDLE EAST AND AFRICA

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, PLG, Quality, Regulatory affairs, Consultant, HCS

With this alliance, PLG reinforces its ability to support client regulatory and compliance needs globally.

Key Points: 
  • With this alliance, PLG reinforces its ability to support client regulatory and compliance needs globally.
  • Health Care Solution was founded in 2016 in Casablanca, Morocco, specializing in Regulatory Affairs, Quality and Industrialization consulting.
  • It offers operational support, audit and training services across Middle East and Africa, leveraging its strong technical and regulatory know-how.
  • The HCS consultants will be involved on larger scale global projects, and PLG will support HCS in opening new doors in Middle East and Africa.

Black Health Matters Winter Health Summit and Expo Returns to Atlanta

Retrieved on: 
Wednesday, February 21, 2024
HCS, Blood pressure, Chronic kidney disease, Merck, Expo, Doctor of Philosophy, BHM, Anemia, Courage, Professor, Lunch, Conditional sentence, Amgen, Cholesterol, Blood, Obesity, DD, Conference, Health, Boehringer Ingelheim, STD, Maternal health, BMI, Lilly, JD, Radio, PSA, WAOK, Guru, Health equity, FREE, Interior design

NEW YORK, Feb. 21, 2024 /PRNewswire/ -- Following an incredibly successful inaugural event in 2023, Black Health Matters (BHM) is once more bringing its celebrated health summit series to Atlanta. On Saturday, March 2nd, 2024, the Black Health Matters Winter Health Summit & Expo will be held at the downtown Atlanta Loudermilk Conference Center, 40 Courtland St. N.E., from 8:30 AM to 4:00 PM EST. This FREE, hybrid (in-person and virtual) event will offer attendees a singular wellness experience, connecting dynamic experts on chronic illness and healthiness, patient advocates and celebrity guests with the public. Those who attend will benefit from free health screenings and immunizations, presentations on chronic disease management, invigorating fitness sessions, entertainment and more. Complimentary breakfast, lunch and parking will be offered, along with FREE giveaways and prizes. To register go to www.bhm2024wintersummit.com for in-person or virtual attendance.

Key Points: 
  • Theme is "Inspiration for Your Mind, Body and Soul"
    NEW YORK, Feb. 21, 2024 /PRNewswire/ -- Following an incredibly successful inaugural event in 2023, Black Health Matters (BHM) is once more bringing its celebrated health summit series to Atlanta.
  • On Saturday, March 2nd, 2024, the Black Health Matters Winter Health Summit & Expo will be held at the downtown Atlanta Loudermilk Conference Center, 40 Courtland St.
  • "The Winter Health Summit and Expo can be your ally on your path to better health and wellness," says Roslyn Young Daniels, founder, and president of Black Health Matters.
  • The Black Health Matters Winter Summit & Expo's impressive list of sponsors includes Amgen, Boehringer Ingelheim, Johnson & Johnson HCS Advocacy, Johnson & Johnson Innovative Medicine Clinical Trials, Lilly, Merck, Pfizer, and Vertex.

Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024

Retrieved on: 
Friday, February 2, 2024
Science, Radiology, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Health Technology, Transverse mode, Drug discovery, RNA interference, AAV, HCS, Drug development, PLX, Medicine, Genomics, CDX, CRISPR, G3, NGS, SLAS, GMP, Automation, Flow cytometry, Omics, Engineering, TB

As the landscape of medicine becomes more personalized, Revvity aims to provide high-value, cutting-edge solutions that foster scientific innovation and positively impact human health.

Key Points: 
  • As the landscape of medicine becomes more personalized, Revvity aims to provide high-value, cutting-edge solutions that foster scientific innovation and positively impact human health.
  • Its offerings are designed to provide differentiated capabilities, providing customers with tools needed for success in precision medicine and beyond.
  • Dr. Alan Fletcher, Revvity’s senior vice president, life sciences, stated, "We're here in our backyard showing how we're seamlessly bringing it all together, powering innovation from research to reality.
  • Revvity will be exhibiting a selection of its extensive range of life sciences and diagnostics products and services.

CAE Adds Nakia Towns and Ingmar Berg to Its Board of Directors

Retrieved on: 
Thursday, January 25, 2024
Student, The NPD Group, Thought, CHEA, Acceleration, CFO, Gwinnett County Public Schools, National academy, School, CAE, George Washington University, Growth, Assistant commissioner of police, Division, Labour, HCS, Hamilton County Schools, Postgraduate education, Organization, Council

Towns served as Deputy Superintendent for Gwinnett County Public Schools, Georgia’s largest district and the 11th largest in the country.

Key Points: 
  • Towns served as Deputy Superintendent for Gwinnett County Public Schools, Georgia’s largest district and the 11th largest in the country.
  • Mr. Berg brings more than two decades of experience in various financial and operational roles for public, private, and private equity-backed companies to CAE’s board.
  • “I am eager to collaborate with my board colleagues to advance the objectives and vision of CAE."
  • “Our board is well equipped to guide CAE in our mission to improve student outcomes,” said Yayac.

Live Cell Imaging Market to Reach $5.2 Billion, Globally, by 2032 at 8.2% CAGR: Allied Market Research

Retrieved on: 
Tuesday, December 12, 2023
B cell, HCS, Cell biology, Observation, Research, Fluorophore, Investment, Biotechnology, Growth, Regenerative medicine, Drug discovery, Cell division, Drug development, Fine chemical, Mobile phone

PORTLAND, Ore., Dec. 12, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Live Cell Imaging Market by Product Type (Instruments, Accessories and Consumables and Software), Application (Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery), Technology (Time-lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-Content Screening (HCS), and Other Technologies) and End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032". According to the report, the global live cell imaging industry generated $2.3 billion in 2022 and is anticipated to generate $5.2 billion by 2032, witnessing a CAGR of 8.2% from 2023 to 2032.

Key Points: 
  • Moreover, it hampers investments in live cell imaging technology development, slowing down innovation and the introduction of advanced imaging systems.
  • Diseases and health concerns persist regardless of economic conditions, potentially leading to sustained demand for live cell imaging technologies in critical areas such as disease research, diagnostics, and drug development.
  • This is attributed to increase in funding allocations research studies, promoting adoption of advanced live cell imaging technologies for varied biological studies.
  • In addition, robust funding environment, coupled with supportive government initiatives, has propelled the adoption of innovative imaging techniques such as live cell imaging in academic and research institutions.

Live Cell Imaging Market to Reach $5.2 Billion, Globally, by 2032 at 8.2% CAGR: Allied Market Research

Retrieved on: 
Tuesday, December 12, 2023
B cell, HCS, Cell biology, Observation, Research, Fluorophore, Investment, Biotechnology, Growth, Regenerative medicine, Drug discovery, Cell division, Drug development, Fine chemical, Mobile phone

PORTLAND, Ore., Dec. 12, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Live Cell Imaging Market by Product Type (Instruments, Accessories and Consumables and Software), Application (Cell Biology, Stem Cells, Developmental Biology, and Drug Discovery), Technology (Time-lapse Microscopy, Fluorescence Resonance Energy Transfer (FRET), Fluorescence Recovery After Photobleaching (FRAP), High-Content Screening (HCS), and Other Technologies) and End User (Pharmaceutical and Biotechnological Companies, Academic and Research Institutes, Contract Research Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2023–2032". According to the report, the global live cell imaging industry generated $2.3 billion in 2022 and is anticipated to generate $5.2 billion by 2032, witnessing a CAGR of 8.2% from 2023 to 2032.

Key Points: 
  • Moreover, it hampers investments in live cell imaging technology development, slowing down innovation and the introduction of advanced imaging systems.
  • Diseases and health concerns persist regardless of economic conditions, potentially leading to sustained demand for live cell imaging technologies in critical areas such as disease research, diagnostics, and drug development.
  • This is attributed to increase in funding allocations research studies, promoting adoption of advanced live cell imaging technologies for varied biological studies.
  • In addition, robust funding environment, coupled with supportive government initiatives, has propelled the adoption of innovative imaging techniques such as live cell imaging in academic and research institutions.